|
Volumn 33, Issue 1-2, 2001, Pages 71-76
|
Megadose approach to DBMC infusion-induced allograft hyporesponsiveness in living-related renal allograft recipients
a,b a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ADOLESCENT;
ADULT;
ALLOGRAFT;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SCHOOL CHILD;
ADOLESCENT;
ADULT;
AGED;
BONE MARROW TRANSPLANTATION;
CHILD;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TRANSPLANTATION TOLERANCE;
|
EID: 0035076740
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02787-1 Document Type: Conference Paper |
Times cited : (16)
|
References (28)
|